Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Pathological response of breast cancer to neoadjuvant chemotherapy (NAC) presents great variability, and new prognostic biomarkers are needed. Our aim was to evaluate the association of the epidermal growth factor receptor gene (EGFR) polymorphism R497K (rs2227983) with prognostic features and clini...

Full description

Bibliographic Details
Main Authors: Marcelo Sobral-Leite, Esther H Lips, Hayra de Andrade Vieira-Monteiro, Letícia Carlos Giacomin, Daniely Regina Freitas-Alves, Sten Cornelissen, Lennart Mulder, Jelle Wesseling, Marjanka K Schmidt, Rosane Vianna-Jorge
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5739423?pdf=render

Internet

http://europepmc.org/articles/PMC5739423?pdf=render

Similar Items